BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
US-based Rad AI Secures $50M Funding Led by Khosla Ventures May 10, 2024 The investment, supported by WiL and existing investors, propels the startup's mission to expand the global reach of its generative AI technology.
Bankrupt Steward Health Puts its 31 US Hospitals Up for Sale Amid $9 Bn Debt Crisis May 9, 2024 In a bid to address its staggering $9 billion debt burden, Steward Health Care, a privately-owned healthcare company, has initiated the sale of all 31 of its hospitals across the United States.
Struggling Steward Health Care Files for Bankruptcy May 8, 2024 US-based healthcare provider Steward Health Care has filed for bankruptcy, citing ongoing financial struggles amidst a turbulent healthcare landscape.
Novo Nordisk Foundation, Wellcome, and Bill & Melinda Gates Foundation Unite to Advance Scientific Research Globally May 8, 2024 In addition to funding scientific research, the partnership will directly support researchers and institutions in low- and middle-income settings.
AstraZeneca Completes Equity Investment with Cellectis May 7, 2024 With this second investment, AstraZeneca now holds a total equity stake of approximately 44% in Cellectis.
PA Clinical Network Partners Guidehealth to Enhance Value-Based Care May 7, 2024 In a bid to bolster value-based care initiatives among physicians in Pennsylvania, the PA Clinical Network has forged a multiyear partnership with Guidehealth, a prominent healthtech company.
Walgreens Partners with Boehringer Ingelheim to Expand Clinical Trials May 6, 2024 The alliance aims to harness Walgreens' expansive network of community pharmacies as pivotal sites for these crucial research endeavors.
Wipro Secures Bid to Implement Medicare Prescription Payment Plan for Independent Health May 3, 2024 The Medicare Prescription Payment Plan will allow Medicare Advantage Part D enrollees to pay for prescription drugs in monthly installments.
Bayer Pharma Concludes JV with Zydus Lifesciences by Acquiring Remaining 25% Stake May 3, 2024 Bayer bought a 25% stake in the JV in April 2018, increasing its ownership interest to 75%. With 25% more, it has now taken full ownership as per pre-agreed JV terms.
US-based neuro42 Bags Investment to Bring Enhanced Neurosurgical Technology May 3, 2024 US-based medtech startup, neuro42 has received an undisclosed amount of investment from serial investor, Karna D Shinde, in his third round of investment in the startup.
Novartis Buys Mariana Oncology for $1 Bn May 3, 2024 Utilizing Mariana's RLT research expertise, Novartis seeks to expedite the development of advanced therapies and tackle key gaps in cancer treatment.
Bayer & Evotec Forge Partnership to Advance Precision Cardiology May 3, 2024 Germany-based two pharmaceutical giants, Bayer and Evotechave have joined forces to develop innovative precision treatments for cardiovascular diseases (CVDs).
